Erika M. Stephens

Papers

Total Citations

H-Index

About

Dr. Erika M. Stephens is a leading surgical oncologist and researcher whose work centers on the intersection of human papillomavirus (HPV)-associated malignancies and patient-centered outcomes. Her primary research areas include head and neck oncology, quality of life (QoL) assessment, and de-escalation treatment strategies for HPV-positive oropharynx cancer. Dr. Stephens’ most cited study, "Prospective quality of life outcomes for human papillomavirus associated oropharynx cancer patients after surgery alone" (2023), is a landmark contribution that demonstrates the feasibility of surgery-only approaches in carefully selected patients, preserving function and minimizing long-term toxicity. This work has garnered 7 citations and is pivotal in shifting clinical paradigms away from aggressive chemoradiation. Her research directly addresses the critical need for personalized, less morbid treatments that maintain excellent oncologic outcomes. Dr. Stephens’ impact extends beyond citation counts; her findings are actively shaping clinical trial designs and multidisciplinary care guidelines. She is recognized for bridging surgical precision with rigorous QoL metrics, ensuring that survival is matched by survivorship. For students and researchers, her work exemplifies how translational research can improve both the quantity and quality of life for cancer patients, making her a vital voice in modern head and neck oncology.